Home > Journals >

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
 

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,102


Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898

Most read articles over the last three weeks

Panminerva Medica 2018 December;60(4):234-5
The effect of probiotics on glycemic index
Rajesh VENKATARAMAN *, Jose JUWAL, Jose PRINCY

Panminerva Medica 2018 December;60(4):228-30
Tetrahydrocannabinol: a drug of interest
Juhi TIWARI, Kartikey BAJPAI, Gaurav GUPTA *, Rahul SHARMA, Rajesh K. VERMA, Kamal DUA

Panminerva Medica 2017 March;59(1):33-46
Methotrexate and lung disease in rheumatoid arthritis
Richard CONWAY, John J. CAREY

Panminerva Medica 2018 December;60(4):223
Anticancer effect of metformin: what about gastric cancer?
Alberto PREMOLI *

Panminerva Medica 2018 December;60(4):232-4
Following a patient with prolonged response against hepatitis E virus
Elitsa N. GOLKOCHEVA-MARKOVA *, Maria PELEVA-PISHMISHEVA, Roberto BRUNI, Umbertina VILLANO, Giulio PISANI, Michele EQUESTRE, Ani KEVORKYAN, Massimo CICCOZZI, Anna R. CICCAGLIONE

Panminerva Medica 2018 December;60(4):230-1
Targeting microRNAs using nanotechnology in pulmonary diseases
Kamal DUA *, Dinesh K. CHELLAPPAN, Gautam SINGHVI, Terezinha de JESUS ANDREOLI PINTO, Gaurav GUPTA, Philip M. HANSBRO

Panminerva Medica 2017 September;59(3):254-68
Catastrophic antiphospholipid syndrome: an update
Gerard ESPINOSA, Ignasi RODRÍGUEZ-PINTÓ, Ricard CERVERA *

Panminerva Medica 2017 June;59(2):149-56
Keto-analogues and essential aminoacids and other supplements in the conservative management of chronic kidney disease
Adamasco CUPISTI, Piergiorgio BOLASCO

Panminerva Medica 2018 December;60(4):174-84
Therapy for relapsed multiple myeloma
Mohammed A. ALJAMA, M. Hasib SIDIQI, David DINGLI *

Panminerva Medica 2017 September;59(3):203-9
The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD
Raymond FARAH*, Rabia IBRAHIM, Majd NASSAR, Dally NAJIB, Yifat ZIVONY, Elizabeth ESHEL

top of page